EP 1392399 A1 20040303 - USE AND COMPOSITIONS OF ANTIPROGESTINS FOR TREATMENT OF PROSTATE DISEASES
Title (en)
USE AND COMPOSITIONS OF ANTIPROGESTINS FOR TREATMENT OF PROSTATE DISEASES
Title (de)
VERWENDUNG UND ZUSAMMENSETZUNGEN MIT ANTIPROGESTINS ZUR BEHANDLUNG VON PROSTATERKRANKUNGEN
Title (fr)
UTILISATION ET COMPOSITIONS D'ANTIPROGESTINES POUR LE TRAITEMENT DE MALADIES DE LA PROSTATE
Publication
Application
Priority
- EP 02745322 A 20020527
- EP 0205819 W 20020527
- EP 01250185 A 20010525
Abstract (en)
[origin: WO02094379A1] The present invention relates to methods and uses for preventing and treating prostate diseases, in particular prostate cancer and benign prostate hyperplasia, in male mammals by antiprogestins, in particular antiprogestins, in particular antirogestin 11ss-(4- acetylphenyl)-17ss-hydroxy-17 alpha -(1,1,2,2,2-pentafluoroethyl)-estra-4,9-dien-3-one or a pharmaceutically acceptable derivative or analogue thereof. The invention further relates to pharmaceutical compositions comprising said antiprogestin.
IPC 1-7
IPC 8 full level
A61K 45/00 (2006.01); A61K 31/565 (2006.01); A61K 31/566 (2006.01); A61K 31/567 (2006.01); A61P 13/08 (2006.01); A61P 15/00 (2006.01); A61P 35/00 (2006.01); C07J 1/00 (2006.01)
CPC (source: EP)
A61K 31/567 (2013.01); A61P 13/08 (2017.12); A61P 15/00 (2017.12); A61P 35/00 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
See references of WO 02094379A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02094379 A1 20021128; AR 034046 A1 20040121; EP 1392399 A1 20040303; JP 2004531561 A 20041014; JP 2010077157 A 20100408; PE 20021138 A1 20030111; UY 27301 A1 20030228
DOCDB simple family (application)
EP 0205819 W 20020527; AR P020101934 A 20020524; EP 02745322 A 20020527; JP 2002591093 A 20020527; JP 2009280715 A 20091210; PE 2002000438 A 20020524; UY 27301 A 20020521